The Real Impact of Peripheral Artery Disease in TAVR

Courtesy of Dr. Carlos Fava.

The real incidence of peripheral artery (PAD) disease in TAVR remains unclear. Different reports still estimate it is between 10 and 46%, but they have shown it has a negative impact in evolution.

Protrusión de placa en angioplastia carotidea ¿Qué riesgo implica y cómo prevenirlo?

51,685 TAVR patients were analyzed. 12,740 of these patients presented PAD (24.6%).

PAD patients tended to be younger, mostly men, smokers, hypertensive, with a history of cardiovascular and carotid disease, chronic obstructive pulmonary disease (COPD), kidney function deterioration and cardiovascular revascularization. There were no differences in obesity and diabetes. In this group, TAVR was done more often in university hospitals.


Read also: ESC 2019 | How Benign Is Moderate Aortic Stenosis?


At hospital level, there were no differences in mortality, need for pacemaker, acute myocardial infarction (AMI), or conversion to surgery. But the presence of PAD was associated to vascular complications [8.6 vs. 5.3%, OR 1.80 (1.50–2.16), p < 0.001], major bleeding [10.8 vs. 8.8%, OR 1.20 (1.09–1.34), p < 0.001], kidney function deterioration [18.2 vs. 15.6%, OR 1.19 (1.05–1.36), p=0.007], cardiac complications [9.4 vs. 8.2%, OR 1.21 (1.01–1.44), p=0.03], stroke [3.2 vs. 2.7%, OR 1.39(1.10–1.75), p=0.005] and longer in-hospital stay [7.23 (0.14) days vs. 7.11 (0.1) days, p < 0.001].

Conclusion

The presence of PAD in TAVR is 25% approximately. This disease was not associated to increased in-hospital mortality, but it was associated to higher risk of vascular complications, major bleeding, kidney function deterioration, stroke, cardiac complications and longer in-hospital stay.

Courtesy of Dr. Carlos Fava.


Original title: Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.

Reference; Divyanshu Mohananey, et, al. Catheter Cardiovasc Interv 2019;94:249-255.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...